Valeant, Ackman may have fight on hands for Allergan

Add to My Stories Print page Add to Favourites

Whilst the US$46bn offer by Canada’s Valeant Pharmaceuticals International and activist investor William Ackman for Allergan, the US pharmaceuticals group that manufactures Botox, has been described as “compelling” we can…